Literature DB >> 15574119

Change in beta1-adrenergic receptor protein concentration in adipose tissue correlates with diet-induced weight loss.

Mads Rasmussen1, Anita Belza, Thomas Almdal, Søren Toubro, Palle Bratholm, Arne Astrup, Niels J Christensen.   

Abstract

The aim of the present study was to examine gene expression and protein concentrations of beta(1)- and beta(2)-adrenergic receptors in subcutaneous adipose tissue in obese subjects in response to weight loss. Eighteen obese subjects were studied during diet-induced weight loss. Beta-adrenergic receptor mRNA levels were quantified by reverse transcription-PCR-HPLC. Beta-adrenergic receptor protein concentrations were measured by Western blotting using fluorescence laser scanning for detection. Subjects lost 12.8+/-0.8 kg (mean+/-S.E.M.) during diet treatment. There was a 34% decrease in the beta(1)-adrenergic receptor mRNA level (0.92+/-0.09 compared with 0.61+/-0.06 amol/microg of DNA; P<0.002). Beta(2)-adrenergic receptor mRNA did not decrease significantly. Beta(2)-adrenergic receptor protein concentration decreased 37% (25.5+/-7.1 compared with 16.0+/-5.6 arbitrary units/ng of DNA; P=0.008), whereas beta(1)-adrenergic receptor protein concentration did not decrease significantly. The degree of weight loss was correlated with the concentration of beta(1)-adrenergic receptor protein (r=0.65, P<0.003) and changes in receptor protein concentration (r=0.50, P=0.035) during the very-low-calorie diet. In conclusion, the present study demonstrates a relationship between beta(1)-adrenergic receptor protein concentration in adipose tissue and the degree of weight loss. This relationship is not directly related to energy expenditure and deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15574119     DOI: 10.1042/CS20040238

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Authors:  Kazuko Masuo
Journal:  Int J Hypertens       Date:  2010-10-21       Impact factor: 2.420

2.  ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.

Authors:  Maha Daghestani; Mazin Daghestani; Mamoon Daghistani; Abdelmoneim Eldali; Zeinab K Hassan; Maha H Elamin; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

3.  Using linkage analysis to identify quantitative trait loci for sleep apnea in relationship to body mass index.

Authors:  E K Larkin; S R Patel; R C Elston; C Gray-McGuire; X Zhu; S Redline
Journal:  Ann Hum Genet       Date:  2008-08-26       Impact factor: 1.670

4.  Relationships of adrenoceptor polymorphisms with obesity.

Authors:  Kazuko Masuo; Gavin W Lambert
Journal:  J Obes       Date:  2011-04-04

Review 5.  Role of adrenergic receptor signalling in neuroimmune communication.

Authors:  Sushanta Chhatar; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-11-25

6.  Obesity is associated with the Arg389Gly ADRB1 but not with the Trp64Arg ADRB3 polymorphism in children from San Luis PotosÍ and León, México.

Authors:  Celia Aradillas-Garc X Cd; Miguel Cruz; Elva Pérez-Luque; María E Garay-Sevilla; Juan M Malacara; Aduna R; Jesús Peralta; Ana Burguete-García; Jorge A Alegría-Torres
Journal:  J Biomed Res       Date:  2016-10-17

7.  The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity.

Authors:  Jash S Parikh; Arshdeep K Randhawa; Sean Wharton; Heather Edgell; Jennifer L Kuk
Journal:  J Obes       Date:  2018-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.